CLINICAL_TRIALS
trial_result
· 2023-07-27
Clinical Trial Update: Effect of Intrathecal Neostigmine on Post-dural Puncture Headache. [Phase 4]
Summary
Phase 4 trial evaluating intrathecal neostigmine for post-dural puncture headache has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexandria University | Conditions: Post-Dural Puncture Headache | Phase 4 | Status: COMPLETED